Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;99(11):e19444.
doi: 10.1097/MD.0000000000019444.

The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients

Yunyao Luo  1   2   3   4 , Ying Nie  1   2   3   4 , Lu Tang  1   2   3   4 , Charles C Xu  5 , Liangzhi Xu  1   2   3   4
Affiliations

The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients

Yunyao Luo et al. Medicine (Baltimore). 2020 Mar.

Abstract

Background: In recent years, there has been an interest in whether environmental endocrine disruptors (EEDs) may contribute to the endocrine disorders in patients with polycystic ovary syndrome (PCOS). The clearance of EEDs from the human body is regulated by the glucuronidation of UDP-glucuronosyltransferases (UGT). This study aimed to analyze the relationship of UGT1A1, UGT2B7, and UGT2B15 polymorphisms with the metabolism of EEDs in patients with PCOS.

Methods: A total of 357 Chinese women (119 PCOS cases and 238 controls) were genotyped for polymorphisms of UGT1A1, UGT2B7, and UGT2B15. The plasma concentrations of EEDs were measured by the gas chromatography-mass spectrometry method. The association between UGT polymorphisms and the serum level of EEDs in patients with PCOS was analyzed.

Results: The UGT2B7 single nucleotide polymorphism was associated with an increased risk of PCOS. The homozygous polymorphism (TT) of UGT2B7 showed higher bisphenol A and PAEs concentrations in serum. However, a single nucleotide polymorphism on UGT2B15 expression was associated with a decreased risk of PCOS. Subjects homozygous for the T allele of UGT2B15 had a significant effect on phthalates in the blood. In addition, our results also showed that the homozygous polymorphism (TT) of UGT2B7 and UGT2B15 was associated with the capacity of the excretion of androgen in patients with PCOS.

Conclusions: Our study reported the novel associations between the UGT polymorphisms and EEDs concentrations in patients with PCOS, supporting the relevance of genetic differences in EEDs metabolism, which might be considered as an etiology of PCOS.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
The association between glucuronosyltransferase (UGT) polymorphisms and environmental endocrine disruptors (EEDs) levels. Hyperandrogenemia (HA). ∗, #P < .05 between the 2 groups, respectively. Data are represented as geometric mean (GM) ± geometric standard deviation (GSD). BPA = bisphenol A, PAE = phthalate, PBDE = polybrominated diphenyl ether, PCOS = polycystic ovary syndrome.
Figure 2
Figure 2
The association between glucuronosyltransferase (UGT) single nucleotide polymorphisms (SNPs) and T, FT levels. Testosterone (T), free testosterone (FT). Data are represented as M ± SD, ∗P < .05. HA = hyperandrogenemia, PCOS = polycystic ovary syndrome.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Barrett ES, Sobolewski M. Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role? Semin Reprod Med 2014;32:166–76. - PMC - PubMed
    1. Yang H, Huang Y, Liu J, et al. Binding modes of environmental endocrine disruptors to human serum albumin: insights from STD-NMR, ITC, spectroscopic and molecular docking studies. Sci Rep 2017;7:11126. - PMC - PubMed
    1. Panidis D, Tziomalos K, Papadakis E, et al. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility. Endocrine 2013;44:583–90. - PubMed
    1. Vahedi M, Saeedi A, Poorbaghi SL, et al. Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome. Environ Sci Pollut Res Int 2016;23:23546–50. - PubMed
    1. Thomas P, Alyea R, Pang Y, et al. Conserved estrogen binding and signaling functions of the G protein-coupled estrogen receptor 1 (GPER) in mammals and fish. Steroids 2010;75:595–602. - PMC - PubMed

Substances